
Dr. Dominique Geoffrion is an Ophthalmology resident at the Université de Montréal. She obtained her medical degree from McGill University in 2023. During her medical training, she also completed a PhD in Experimental Surgery at McGill. She previously earned her Honors Bachelor's degree in Biomedical Sciences from the Université de Montréal.
Dr. Geoffrion has conducted extensive research in molecular biology, genetics, and ophthalmology, resulting in multiple publications, including in prestigious medical journals like The New England Journal of Medicine. Her PhD research enhanced the understanding and management of glaucoma after Boston keratoprosthesis surgery. Additionally, she serves as an ad hoc reviewer for various ophthalmology journals.
Dr. Geoffrion has received numerous scholarships and awards from the American Academy of Ophthalmology (2024 Artemis Award), the American Society of Cataract and Refractive Surgery, the Canadian Ophthalmological Society, McGill University, as well as the Canadian Institutes of Health Research and the Quebec Health Research Funds. She has namely been recognized as one of Canada's Top 100 Most Powerful Women. Committed to global ophthalmology, Dr. Geoffrion has served as a Board member of Orbis Canada since 2021. She participated in the Orbis Flying Eye Hospital program in Bangladesh as an Associate Ophthalmologist in November 2024. She is the founder and president of the Orbis Future Vision Leaders program, an initiative by Orbis Canada designed to bring together medical students and residents to fight avoidable blindness.
Financial disclosure: Dr. Geoffrion has/had an affiliation (financial or otherwise) with a commercial organization:
1. OpenAI - medical consultant for safety of AI-generated responses for medical advice